Ceragenix Pharmaceuticals, Inc. Appoints Dr. Donald Leung To Its Scientific Advisory Board

February 21, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Ceragenix Pharmaceuticals, Inc. ("Ceragenix"), a biopharmaceutical company focused on infectious disease and dermatology, today announced that it has appointed Donald Leung, M.D., Ph.D., to its Scientific Advisory Board.

Twitter
LinkedIn
Facebook
Email
Print

People